Correlation Between CorMedix and Oric Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CorMedix and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CorMedix and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CorMedix and Oric Pharmaceuticals, you can compare the effects of market volatilities on CorMedix and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CorMedix with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CorMedix and Oric Pharmaceuticals.

Diversification Opportunities for CorMedix and Oric Pharmaceuticals

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between CorMedix and Oric is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding CorMedix and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and CorMedix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CorMedix are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of CorMedix i.e., CorMedix and Oric Pharmaceuticals go up and down completely randomly.

Pair Corralation between CorMedix and Oric Pharmaceuticals

Given the investment horizon of 90 days CorMedix is expected to generate 1.11 times more return on investment than Oric Pharmaceuticals. However, CorMedix is 1.11 times more volatile than Oric Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest  418.00  in CorMedix on September 23, 2024 and sell it today you would earn a total of  439.00  from holding CorMedix or generate 105.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CorMedix  vs.  Oric Pharmaceuticals

 Performance 
       Timeline  
CorMedix 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CorMedix are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, CorMedix exhibited solid returns over the last few months and may actually be approaching a breakup point.
Oric Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

CorMedix and Oric Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CorMedix and Oric Pharmaceuticals

The main advantage of trading using opposite CorMedix and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CorMedix position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.
The idea behind CorMedix and Oric Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account